Results 191 to 200 of about 1,586,237 (267)

Cost-Effectiveness Analysis of Triple Oral Antidiabetic Drug Combination in Patients With Type 2 Diabetes Mellitus: An Outpatient Study in Indonesia. [PDF]

J ASEAN Fed Endocr Soc
Hanifiyah IA, Nita Y, Libriansyah, Ridwan A, Achmad GNV.   +4 more
europepmc   +1 more source

Sodium-glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial. [PDF]

J Diabetes Investig
Takatsuna Y, Ishibashi R, Koshizaka M, Tatsumi T, Baba T, Yamamoto S, Yokote K.   +6 more
europepmc   +1 more source

[Case of hypersensitivity to sulfonylurea compounds].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1983
openaire   +1 more source

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study. [PDF]

Diabetes Obes Metab
Engström A, Svanström H, Hviid A, Eliasson B, Gudbjörnsdottir S, Wintzell V, Hveem K, Jonasson C, Melbye M, Ueda P, Pasternak B.   +10 more
europepmc   +1 more source

Controllable Ion-Repulsion Enables Rapid and Trace-Level Detection of Hydrophobic Sulfonylurea Herbicides with ICPMS/MS without the Organic Mode. [PDF]

Anal Chem
Lajin B, Goessler W.
europepmc   +1 more source

ArcDFI: Attention regularization guided by CYP450 interactions for predicting drug-food interactions. [PDF]

PLoS Comput Biol
Gim M, Kang J, Park D, Jeon M.
europepmc   +1 more source

Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. [PDF]

Drug Saf
Bea S, Patorno E, Hahn G, Paik JM, Wexler DJ, Bykov K.   +5 more
europepmc   +1 more source

Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure. [PDF]

J Am Soc Nephrol
Catanese B, Miller C, Wolf M, Edmonston D.   +3 more
europepmc   +1 more source

Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease. [PDF]

Medicine (Baltimore)
Seo DH, Ha KH, Kim SH, Kim DJ.
europepmc   +1 more source

Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated <i>in vitro</i> tests. [PDF]

Front Chem
Culletta G, Roomi MS, Caricasulo MA, Zanetti A, Terao M, Paroni G, Garattini E, Tutone M.   +7 more
europepmc   +1 more source